Get the Stockscreener App
7.76
3.47%
0.26
Dariohealth Corp stock is traded at $7.76, with a volume of 9,260.
It is up +3.47% in the last 24 hours and down -31.08% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
See More
Previous Close:
$7.50
Open:
$7.37
24h Volume:
9,260
Relative Volume:
0.54
Market Cap:
$52.45M
Revenue:
$22.36M
Net Income/Loss:
$-33.61M
P/E Ratio:
-0.8064
EPS:
-9.6235
Net Cash Flow:
$-26.08M
1W Performance:
-11.31%
1M Performance:
-31.08%
6M Performance:
-19.08%
1Y Performance:
-44.57%
1-Day Range:
$7.37
$8.37
1-Week Range:
$7.37
$9.37
52-Week Range:
$5.935
$17.74
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
7.76 | 52.45M | 22.36M | -33.61M | -26.08M | -9.6235 |
VEEV
Veeva Systems Inc
|
179.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
48.83 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.31 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.10 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.03 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
DarioHealth says CFO Zvi Ben-David to retire, appoints Chen Franco-Yehuda as successor - MSN
DarioHealth Corp stock faces investor scrutiny amid digital health market shifts and cash burn conce - AD HOC NEWS
Weekly Recap: Is DarioHealth Corp a stock for growth or value investors2026 Big Picture & Real-Time Market Sentiment Reports - baoquankhu1.vn
If You Invested $1,000 in Dariohealth Corp (DRIO) - Stock Titan
DarioHealth files to sell 2.71M shares of common stock for holders - MSN
Insider Trends: Will DarioHealth Corp stock go up in YEARTrade Ideas & Community Shared Stock Ideas - baoquankhu1.vn
DarioHealth (DRIO): Stifel Analyst Lowers Price Target to $10 | - GuruFocus
DarioHealth Corp. (DRIO) reports Q4 loss, beats revenue estimates - MSN
DarioHealth (NASDAQ:DRIO) Price Target Lowered to $10.00 at Stifel Nicolaus - MarketBeat
Stifel Maintains DarioHealth(DRIO.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
DarioHealth Corp. (NASDAQ:DRIO) Q4 2025 Earnings Call Transcript - Insider Monkey
DarioHealth Corp. (NASDAQ: DRIO) registers $100M shelf for future securities - Stock Titan
DarioHealth 2025 Financial Results & 2026 Revenue Growth ForecastNews and Statistics - IndexBox
DarioHealth (DRIO) Fourth Quarter 2025 Earnings Call Transcript - Bitget
DarioHealth Corp. Q4 2025 Earnings Call Summary - Yahoo Finance
DarioHealth (DRIO) Q4 2025 Earnings Transcript - The Globe and Mail
Earnings call transcript: DarioHealth sees revenue dip in Q4 2025 By Investing.com - Investing.com Australia
DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - Finviz
DarioHealth Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: DarioHealth sees revenue dip in Q4 2025 - Investing.com
DarioHealth (NASDAQ:DRIO) Issues Earnings Results - MarketBeat
DarioHealth Corp reports results for the quarter ended December 31Earnings Summary - TradingView
DarioHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
DarioHealth Q4 revenue USD 5.2 million versus Ibes estimate USD 5.05 million - marketscreener.com
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
DarioHealth Reports Strong 2025 Financial Results and Strategic Updates - Intellectia AI
DarioHealth 2025 10-K: Revenues $22.4M, Net loss per share and $61.7M loss to common stockholders - TradingView
DarioHealth (NASDAQ: DRIO) weighs options after strategic review move - Stock Titan
DarioHealth Corp. (DRIO) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
DRIO PE Ratio & Valuation, Is DRIO Overvalued - Intellectia AI
Work begins three-tired plan for State Health Plan - AOL.com
DarioHealth Corp expected to post a loss of $3.24 a shareEarnings Preview - TradingView
Performance Recap: Will DarioHealth Corp announce a stock splitQuarterly Earnings Report & Expert Approved Trade Ideas - baoquankhu1.vn
DarioHealth Corp Stock (ISIN: US23209T1051) Eyes Digital Health Expansion Amid Competitive Pressure - AD HOC NEWS
DarioHealth Corp Stock (ISIN: US23209T1051) Faces Digital Health Crossroads as Payer Pressure Mounts - AD HOC NEWS
Short Interest in DarioHealth Corp. (NASDAQ:DRIO) Drops By 24.6% - MarketBeat
DRIO SEC FilingsDariohealth Corp 10-K, 10-Q, 8-K Forms - Stock Titan
DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026 - The Malaysian Reserve
DarioHealth study shows blood glucose improvements in users By Investing.com - Investing.com South Africa
DarioHealth study shows blood glucose improvements in users - Investing.com Australia
DarioHealth Corp. Announces Publication of New Peer-Reviewed Research in Frontiers in Digital Health Demonstrating Substantial and Sustained Blood Glucose Improvements Among Users of the Dario Platform - marketscreener.com
Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health - Nasdaq
DarioHealth (DRIO) Price Target Decreased by 13.31% to 22.70 - MSN
Dividend Watch: Is DarioHealth Corp.’s growth already priced inWeekly Profit Summary & Free Community Consensus Stock Picks - baoquankhu1.vn
Litchfield Hills Initiates Coverage of DarioHealth (DRIO) with Buy Recommendation - MSN
Novant on board with Lantern, state health plan - AOL.com
DRIO Technical Analysis & Stock Price Forecast - Intellectia AI
DRIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Th - GuruFocus
DarioHealth Corpsees increased demand for oral GLP-1 solution - marketscreener.com
Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management - PR Newswire
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.50%
2.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):